Difference between revisions of "Team:ASIJ TOKYO/Attributions"
| Line 2,987: | Line 2,987: | ||
.features article { | .features article { | ||
padding: 1.75em 1.75em 0.1em 1.75em ; | padding: 1.75em 1.75em 0.1em 1.75em ; | ||
| − | background-color: # | + | background-color: #dbe9d8; |
border-radius: 5px; | border-radius: 5px; | ||
margin: 1.5em 3em 1.5em 0; | margin: 1.5em 3em 1.5em 0; | ||
| Line 3,663: | Line 3,663: | ||
.wrapper.style2 { | .wrapper.style2 { | ||
| − | background-color: # | + | background-color: #dbe9d8; |
} | } | ||
| Line 3,671: | Line 3,671: | ||
.wrapper.style2:before { | .wrapper.style2:before { | ||
| − | box-shadow: inset 0 -1px 0 0 # | + | box-shadow: inset 0 -1px 0 0 #dbe9d8, 0 1px 0 0 #dbe9d8; |
} | } | ||
.wrapper.style2:after { | .wrapper.style2:after { | ||
| − | box-shadow: inset 0 -1px 0 0 # | + | box-shadow: inset 0 -1px 0 0 #dbe9d8, 0 1px 0 0 #dbe9d8; |
} | } | ||
.wrapper.style3 { | .wrapper.style3 { | ||
| − | background-color: # | + | background-color: #dbe9d8; |
} | } | ||
| Line 3,687: | Line 3,687: | ||
.wrapper.style3:before { | .wrapper.style3:before { | ||
| − | box-shadow: inset 0 -1px 0 0 # | + | box-shadow: inset 0 -1px 0 0 #dbe9d8, 0 1px 0 0 #dbe9d8; |
} | } | ||
.wrapper.style3:after { | .wrapper.style3:after { | ||
| − | box-shadow: inset 0 -1px 0 0 # | + | box-shadow: inset 0 -1px 0 0 #dbe9d8, 0 1px 0 0 #dbe9d8; |
} | } | ||
| Line 3,820: | Line 3,820: | ||
.wrapper.spotlight.style3 { | .wrapper.spotlight.style3 { | ||
| − | background-color: # | + | background-color: #dbe9d8; |
} | } | ||
| Line 3,828: | Line 3,828: | ||
.wrapper.spotlight.style3:before { | .wrapper.spotlight.style3:before { | ||
| − | box-shadow: inset 0 -1px 0 0 # | + | box-shadow: inset 0 -1px 0 0 #dbe9d8, 0 1px 0 0 #dbe9d8; |
} | } | ||
.wrapper.spotlight.style3:after { | .wrapper.spotlight.style3:after { | ||
| − | box-shadow: inset 0 -1px 0 0 # | + | box-shadow: inset 0 -1px 0 0 #dbe9d8, 0 1px 0 0 #dbe9d8; |
} | } | ||
.wrapper.spotlight.style4 { | .wrapper.spotlight.style4 { | ||
| − | background-color: # | + | background-color: #dbe9d8; |
} | } | ||
| Line 3,844: | Line 3,844: | ||
.wrapper.spotlight.style4:before { | .wrapper.spotlight.style4:before { | ||
| − | box-shadow: inset 0 -1px 0 0 # | + | box-shadow: inset 0 -1px 0 0 #dbe9d8, 0 1px 0 0 #dbe9d8; |
} | } | ||
.wrapper.spotlight.style4:after { | .wrapper.spotlight.style4:after { | ||
| − | box-shadow: inset 0 -1px 0 0 # | + | box-shadow: inset 0 -1px 0 0 #dbe9d8, 0 1px 0 0 #dbe9d8; |
} | } | ||
| Line 4,342: | Line 4,342: | ||
#header { | #header { | ||
| − | background-color: # | + | background-color: #dbe9d8; |
} | } | ||
Revision as of 12:43, 31 October 2017
Attributions
All lab work was conducted at the American School in Japan by team members of the 2017 ASIJ iGEM team."
Project Support and Advice
Project Advisor: Ms. Beth Crissy supervised our lab activity and provided presentation coaching
Project Support and Advice
Tokyo Tech iGEM Team: Gave us feedback on the presentation of our results.
Dr. Akihiro Abe: Taught us about the current advances in immunological therapy for colorectal cancer
Taipei American School, Mr. Jude Clapper (2017 TAS iGEM team): Technical support on our experiments and wiki.
Tokyo Tech iGEM Team: Gave us feedback on the presentation of our results.
2015 Peking iGEM Team: Inspired us on our construct design.
Lab Support
Integrated DNA Technologies (IDT): Provided us with parts of DNA for our construct.
Wiki Support
Alex Shin & Everett Xu: Made this page and other pages.
Human Practices
ASIJ administration: Thank you for all of our in-school events: Blue Out Day, Back-to-School Night presentation, Relay for Life, Summer Passport Lab Work, and MPR Student Presentation.
Mr. Ed Gilmartin: Shared his personal story as a colorectal cancer survivor with the iGEM team.
Ms. Carole Nickle: Shared her personal story as a colorectal cancer survivor with the iGEM team.
Athena Brooks: Helped us reach out to the Japanese community by getting permission to hand out brochures.
Collaborators
Tokyo Tech iGEM Team: Sharing project ideas with each other and supporting our research.
Work Cited
American Cancer Society, What Is Colorectal Cancer? 6 Apr. 2017. https://www.cancer.org/cancer/colon-rectal-cancer/about/what-is-colorectal-cancer.html
Aoki, Koji. Adenomatous Polyposis Coli (APC): a Multi-Functional Tumor Suppressor Gene. Journal of Cell Science, The Company of Biologists Ltd, 1 Oct. 2007, https://doi.org/10.1242/jcs.03485 (jcs.biologists.org/content/120/19/3327.)
Peking iGEM Team 2015, Fighting Against Tuberculosis Visualizing Nucleic Acid Detection:Project. Team:Peking/Design/PC Reporter, Peking iGEM Team 2015, 2015, 2015.igem.org/Team:Peking/Design/PC_Reporter.
SEER Cancer Stat Facts: Colon and Rectum Cancer. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/colorect.html (This citation is public domain)
Tomonao Inobe, Nobuyuki Nukina, Rapamycin-induced oligomer formation system of FRB–FKBP fusion proteins, In Journal of Bioscience and Bioengineering, Volume 122, Issue 1, 2016, Pages 40-46, ISSN 1389-1723, https://doi.org/10.1016/j.jbiosc.2015.12.004. (http://www.sciencedirect.com/science/article/pii/S1389172315004417)
